Address: 12 Erazma Ciołka Str, 01-402 Warsaw
,Poland
Tel: +48 22 254 24 84
ClinMed Pharma is a Polish Clinical Research Organization cooperating with pharmaceutical, CRO and biotech companies in all phases of clinical trials, as well as non-interventional studies.
Our mission is to provide high quality services with much personal attention and to customise the services to the needs of our clients.
ClinMed Pharma personnel show great commitment to all projects not only ensuring the proper study conduct required by the local law, GCP standards and Sponsor’s SOPs but also good and long-term relationships with investigators due to the professional and reliable approach.
ClinMed Pharma is experienced in site contract negotiation as well as submission of Clinical Trial Application to Regulatory Authority and Ethics Committee.
Moving to the next step of the project, our CRAs perform all activities necessary for ongoing monitoring of the study with great focus on quality. As far as audit preparation is concerned, our staff has the medical, technical and regulatory expertise to ensure that standards, processes and personnel are in place to achieve the highest quality. We also deliver training increasing the quality pivotal for the conduct of clinical studies.
Sabina Sampławska, director, head of life sciences at KPMG Poland, discusses the challenge of pricing pressures and how their innovative services help companies manage this trend, as well as the…
Michael Kern, director general of the German Chamber of Commerce in Poland, discusses the evolving economic and business landscape in Poland and the overall impact of German companies. Furthermore, he…
Adam Czerw, country manager of LEO Pharma Poland, discusses the impressive growth of the affiliate, especially since the global 2016 purchase of Astellas’ dermatology portfolio, as well as the encouraging…
Michał Pietraszek, general manager of Apotex Poland, the leading Canadian generics powerhouse, discusses the affiliate’s strategic move into the OTC and food supplement business and the company’s niche-market approach to…
Michael Dembinski, chief advisor of the British Polish Chamber of Commerce, discusses the important role of the chamber in driving forward Polish clinical trials and the challenges in unlocking Poland’s…
Mirosław Wysocki, national consultant in the area of Public Health, professor at the National Institute of Public Health (NIH), the research institute responsible inter alia for health promotion and disease…
Monika Constant, director general of the French-Polish Chamber of Commerce in Poland (CCIFP), discusses the evolution of the two nations’ bilateral business relationship, the benefits of conducting business in Poland,…
Beata Ambroziewicz, board member of the Polish cancer patient coalition, an umbrella organization that encompasses 41 Polish cancer organizations, discusses the challenges and possible solutions in regard to hospital care…
Bogna Cichowska-Duma, general director of the Employers’ Association of Innovative Pharmaceutical Companies (INFARMA), the voice of 28 leading innovative companies in Poland, discusses the challenges and opportunities for doing research…
Marcin Czech, deputy minister and undersecretary of state at the Polish Ministry of Health, provides an in-depth perspective on Poland’s drug policy framework and the new medicines policy that aims…
Mirosław Zieliński, president of the Polish National Forum for the Therapy of rare diseases (ORPHAN), the representative voice for 35 Polish rare disease associations, discusses the implications of the introduction…
Wojciech Kuta, editor-in-chief of Rynek Zdrowia, a leading Polish healthcare publication, discusses the interacting dynamics of the obstacles facing Polish healthcare, as the country aims to increase healthcare spending to…
See our Cookie Privacy Policy Here
